Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis begins shake-up

This article was originally published in Scrip

Executive Summary

Chris Viehbacher, the newly appointed CEO ofSanofi-Aventis, has implemented a number of organisational changes just days after taking up the position. Jean-Claude Leroy, executive vice-president finance and legal, is to leave his position and will be replaced by Laurence Debroux as senior vice-president and chief financial officer. Sanofi-Aventis has also appointed Karen Linehan senior vice-president of legal affairs and general counsel. Ms Debroux and Ms Linehan, who are both members of the executive committee and the group management committee, will now report directly to Mr Viehbacher. Mr Viebacher joined Sanofi-Aventis at the beginning of this month after leaving his position asGlaxoSmithKline's president of North American pharmaceutical operations.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC008024

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel